198 related articles for article (PubMed ID: 8707088)
1. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.
Hommes DW; Meenan J; de Haas M; ten Kate FJ; von dem Borne AE; Tytgat GN; van Deventer SJ
Gut; 1996 Apr; 38(4):564-7. PubMed ID: 8707088
[TBL] [Abstract][Full Text] [Related]
2. NA-phenotype-dependent differences in neutrophil Fc gamma RIIIb expression cause differences in plasma levels of soluble Fc gamma RIII.
Koene HR; de Haas M; Kleijer M; Roos D; von dem Borne AE
Br J Haematol; 1996 Apr; 93(1):235-41. PubMed ID: 8611467
[TBL] [Abstract][Full Text] [Related]
3. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
5. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
6. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.
Troncone R; Caputo N; Campanozzi A; Cucciardi M; Esposito V; Russo R; De Vizia B; Greco L; Cucchiara S
Gut; 1997 Jul; 41(1):60-5. PubMed ID: 9274473
[TBL] [Abstract][Full Text] [Related]
7. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis.
Konstan MW; Walenga RW; Hilliard KA; Hilliard JB
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):896-901. PubMed ID: 8214945
[TBL] [Abstract][Full Text] [Related]
9. Eicosanoids content in small intestinal mucosa of children with celiac disease.
Branski D; Hurvitz H; Halevi A; Klar A; Navon P; Weidenfeld J
J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):173-6. PubMed ID: 1317423
[TBL] [Abstract][Full Text] [Related]
10. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
11. Whole gut lavage fluid interleukin-1beta and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remission.
Arnott ID; Williams N; Drummond HE; Ghosh S
Dig Liver Dis; 2002 Jun; 34(6):424-9. PubMed ID: 12132790
[TBL] [Abstract][Full Text] [Related]
12. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
13. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
15. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls.
Ellrichmann M; Wietzke-Braun P; Dhar S; Nikolaus S; Arlt A; Bethge J; Kuehbacher T; Wintermeyer L; Balschun K; Klapper W; Schreiber S; Fritscher-Ravens A
Aliment Pharmacol Ther; 2014 Apr; 39(8):823-33. PubMed ID: 24612000
[TBL] [Abstract][Full Text] [Related]
17. Consequences of Fc gamma receptor type III reactivity in non-organ-specific autoimmune diseases.
Youinou P; Renaudineau Y
Biochem Soc Trans; 2002 Aug; 30(4):819-24. PubMed ID: 12196206
[TBL] [Abstract][Full Text] [Related]
18. Soluble Fc gamma RIIIa is present in plasma and is derived from natural killer cells.
de Haas M; Kleijer M; Minchinton RM; Roos D; von dem Borne AE
J Immunol; 1994 Jan; 152(2):900-7. PubMed ID: 8283059
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
[TBL] [Abstract][Full Text] [Related]
20. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
